Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study
- PMID: 6193755
- DOI: 10.1007/BF00393676
Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study
Abstract
Ribosomal ribonucleic acid (RNA) and lipopolysaccharide (LPS) from P. aeruginosa were compared with respect to their protective activities in mice against an infection with P. aeruginosa. This study is concentrated on the protective activity of RNA. RNA isolated from purified ribosomes did not contain LPS as determined with the Limulus test. Injection of RNA with the adjuvant dimethyldioctadecylammonium bromide (DDA) protected mice against P. aeruginosa without inducing LPS-specific antibodies. C3H/HeJ mice which are relatively insensitive to the protective activity of LPS could be protected with RNA. The protective activities of RNA and LPS from a mutant strain of P. aeruginosa, PAC 605, containing defective lipopolysaccharide, were compared with the protective activities of RNA and LPS from the parent strain, PAC IR. The protective activity of LPS from PAC 605 was 1000 fold lower than the protective activity of LPS from PAC IR. RNA preparations of both strains induced similar percentages of survival. The protective activity of ribosomal RNA from P. aeruginosa was nonspecific since mice were also protected against a heterologous serotype of P. aeruginosa and against Escherichia coli. RNA from ribosomes of P. aeruginosa, E. coli and the non-lipopolysaccharide containing Saccharomyces cerevisiae had similar protective activities. No protection was obtained with the ribonucleic acid from the E. coli phage MS2. It is concluded that ribosomal RNA has protective activities distinct from those of LPS.
Similar articles
-
Ribonuclease-sensitive ribosomal vaccines.Antonie Van Leeuwenhoek. 1984;50(5-6):763-74. doi: 10.1007/BF02386239. Antonie Van Leeuwenhoek. 1984. PMID: 6084981
-
Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.Infect Immun. 1981 Jul;33(1):178-85. doi: 10.1128/iai.33.1.178-185.1981. Infect Immun. 1981. PMID: 6167518 Free PMC article.
-
Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.Infect Immun. 1981 Mar;31(3):896-905. doi: 10.1128/iai.31.3.896-905.1981. Infect Immun. 1981. PMID: 6785242 Free PMC article.
-
Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.Invest Ophthalmol Vis Sci. 1997 Jun;38(7):1418-25. Invest Ophthalmol Vis Sci. 1997. PMID: 9191605
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
Cited by
-
Antibacterial resistance, macrophage influx, and activation induced by bacterial rRNA with dimethyldioctadecylammonium bromide.Infect Immun. 1985 Dec;50(3):728-33. doi: 10.1128/iai.50.3.728-733.1985. Infect Immun. 1985. PMID: 2415454 Free PMC article.
-
RNase-sensitive and RNase-insensitive protective components isolated from Listeria monocytogenes.Antonie Van Leeuwenhoek. 1985;51(2):227-40. doi: 10.1007/BF02310015. Antonie Van Leeuwenhoek. 1985. PMID: 2412492
-
Ribonuclease-sensitive ribosomal vaccines.Antonie Van Leeuwenhoek. 1984;50(5-6):763-74. doi: 10.1007/BF02386239. Antonie Van Leeuwenhoek. 1984. PMID: 6084981